Hadi Pranoto in a video interview with Anji in the spotlight of netizens because of the excitement claiming the drug COVID-19. The medicine that Hadi claims is called Bio Nuswa, but this matter was immediately denied by the Bio Nuswa distribution permit holder.
Because, Nuswa Bio stressed that the efficacy of its products did not include ‘healing patients COVID-19‘. The usefulness of Bio Nuswa itself is to focus on maintaining endurance.
It is clearly stated in the release received by AFP related to ‘clarification’. Bio Nuswa warns if there are other products that include certain marketing authorization numbers from BPOM.
“Claims for the” BIO NUSWA “product with the POM TR203636031 Distribution License Number that we registered are helping maintain body endurance, not healing patients who are exposed to the covid-19 virus as in recent reports,” said a release received by AFP on Wednesday (5 / 8/2020).
The following is a complete clarification from Bio Nuswa regarding the claim of COVID-19 drug which was later excitedly discussed in a release received by AFP.
1. PT. Sarakamandiri Semesta, located in Mt. Putri Bogor, is indeed a manufacturer or manufacturer of “Traditional Medicine” that has a CPOTB permit and is certified with a Halal Guarantee System.
2. Distribution License Number POM TR 203636031 is true that the Distribution License Number of PT. Sarakamandiri Semesta which has been registered with BPOM.
3. As the holder of the Distribution Permit Number, PT. Sarakamandiri Semesta has never produced such a product since the Circular No License was issued by BPOM on April 14, 2020 until today, August 4, 2020.
4. If there is a “BIO NUSWA” product or other product that includes the POM Circular License Number TR203636031 on the market, then we can be sure that the product is not a production of PT. Sarakamandiri Semesta, so that the quality and authenticity of these products is not our responsibility.
5. Claims for “BIO NUSWA” products with the POM TR203636031 Distribution License Number that we have registered is “Helps maintain endurance” not cure patients who are exposed to the covid-19 virus as in recent reports.
6. Since July 10, 2020, we have submitted the Return of Distribution License Number for “BIO NUSWA” products to BPOM, but due to mismatch of e-mail addresses, the data has not been received by BPOM. After we made clarification with BPOM then on August 3, 2020, we resubmitted the return of the “BIO NUSWA” product distribution license number
Watch Video “Claiming to Find COVID-19 Medication, Hadi Pranoto Explains the Basic Ingredients“
[Gambas:Video 20detik]
(naf/up)
–
